Cholesterol homeostasis: a key to prevent or slow down neurodegeneration
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 3, 40078
Abstract
Neurodegeneration, a common feature for many brain disorders, has severe consequences on the mental and physical health of an individual. Typically human neurodegenerative diseases are devastating illnesses that predominantly affect elderly people, progress slowly, and lead to disability and premature death; however they may occur at all ages. Despite extensive research and investments, current therapeutic interventions against these disorders treat solely the symptoms. Therefore, since the underlying mechanisms of damage to neurons are similar, in spite of etiology and background heterogeneous, it will be of interest to identify possible trigger point of neurodegeneration enabling development of drugs and/or prevention strategies that target many disorders simultaneously. Among the factors that have been identified so far to cause neurodegeneration, failures in cholesterol homeostasis are indubitably the best investigated. The aim of this review is to critically discuss some of the main results reported in the recent years in this field mainly focusing on the mechanisms that, by recovering perturbations of cholesterol homeostasis in neuronal cells, may correct clinically relevant features occurring in different neurodegenerative disorders and, in this regard, also debate the current potential therapeutic interventions.Keywords
This publication has 90 references indexed in Scilit:
- Lipid raft: A floating island of death or survivalToxicology and Applied Pharmacology, 2012
- ACAT inhibition and amyloid beta reductionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid–Alzheimer's disease relationships?Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with ADProceedings of the National Academy of Sciences, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- A systems approach to prion diseaseMolecular Systems Biology, 2009
- Lipid rafts, cholesterol, and the brainNeuropharmacology, 2008
- Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosisNature Medicine, 2008
- Cholesterol Controls Lipid Endocytosis through Rab11Molecular Biology of the Cell, 2007
- Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesisProceedings of the National Academy of Sciences, 2006